Search

Jana S Ulmer

from Sebastopol, CA
Age ~68
Get Report
Also known as:
Jana Seymour Ulmer, Jana L Ulmer, David E Ulmer, Jana L Seymour, David Eugene Ulmer
Phone and address:
7157 Camellia Ln, Sebastopol, CA 95472
(707) 527-6669
Related to:
Harrison W SeymourLisa U Mink, 58Doris K Ulmer, 87H W SeymourLaura M SeymourDavid Ulmer, 54Evelyn L Seymour, 76David E Ulmer, 85Laura M Seymour, 42Betty J SeymourDavid R Farmer, 43Melissa J Ulmer, 30David M Seymour, 75
Connected to:
Andrew M Ulmer, 79Angelique O Ulmer, 53Ashley R Ulmer, 38Bradley C Ulmer, 62Catrina N Ulmer, 47Cedrick J Ulmer, 44Dale S Ulmer, 68Dean V Ulmer, 63Donnalyn M Ulmer, 72Ernest H Ulmer, 81

Jana Ulmer Phones & Addresses

  • 7157 Camellia Ln, Sebastopol, CA 95472 (707) 527-6669 (707) 824-1650
  • Bellevue, WA
  • 4 Miramar Ave, San Rafael, CA 94901
  • Santa Rosa, CA
  • Rodeo, CA
  • San Mateo, CA
  • Oakland, CA

Publications

Us Patents

Human Dnase I Variants

View page
US Patent:
6348343, Feb 19, 2002
Filed:
Feb 28, 2001
Appl. No.:
09/796774
Inventors:
Robert A. Lazarus - Millbrae CA
Steven Shak - Burlingame CA
Jana S. Ulmer - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 922
US Classification:
435199, 424 946, 536 232
Abstract:
The present invention relates to amino acid sequence variants of human DNase I that have reduced binding affinity for actin. The invention provides nucleic acid sequences encoding such actin-resistant variants, thereby enabling the production of these variants in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and therapeutic uses of actin-resistant variants of human DNase I.

Pharmaceutical Administration Of Ecotin Homologs

View page
US Patent:
58438955, Dec 1, 1998
Filed:
May 11, 1995
Appl. No.:
8/439005
Inventors:
Robert A. Lazarus - Millbrae CA
Mark S. Dennis - San Carlos CA
Jana Seymour Ulmer - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 1481
A61K 3855
US Classification:
514 12
Abstract:
A potent serine protease inhibitor capable of inhibiting Factor Xa, Factor XIIa, plasma kallikrein, and human leukocyte elastase is provided. The inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of Factor Xa, Factor XIIa, plasma kallikrein, or HLE is indicated.

Dna Encoding Ecotin Homologs

View page
US Patent:
57190410, Feb 17, 1998
Filed:
May 11, 1995
Appl. No.:
8/439534
Inventors:
Robert A. Lazarus - Millbrae CA
Mark S. Dennis - San Carlos CA
Jana Seymour Ulmer - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12P 2102
C12N 1563
C12N 121
C07H 2104
US Classification:
435 692
Abstract:
A potent serine protease inhibitor capable of inhibiting Factor Xa, Factor XIIa, plasma kallikrein, and human leukocyte elastase is provided. The inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of Factor Xa, Factor XIIa, plasma kallikrein, or HLE is indicated.

Pharmaceutical Compositions Containing Ecotin And Homologs Thereof

View page
US Patent:
61138967, Sep 5, 2000
Filed:
Oct 4, 1994
Appl. No.:
8/319501
Inventors:
Robert A. Lazarus - Millbrae CA
Mark S. Dennis - San Carlos CA
Jana Seymour Ulmer - San Rafael CA
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 3855
C12N 948
C07K 1481
US Classification:
424 9464
Abstract:
A potent serine protease inhibitor capable of inhibiting Factor Xa, Factor XIIa, plasma kallikrein, and human leukocyte elastase is provided. The inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of Factor Xa, Factor XIIa, plasma kallikrein, or HLE is indicated.
Control profile
Jana S Ulmer from Sebastopol, CA, age ~68 Get Report